Grown Rogue International (GRIN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
17 Nov, 2025Executive summary
Navigated industry volatility and regulatory changes, focusing on controllable factors like yield, cost, and operational excellence.
Pro Forma Revenue and Adjusted EBITDA, including New Jersey affiliate, reached $8.5M and $1.7M, up 26% and 25% year-over-year, reflecting operational improvements and market expansion.
Maintained disciplined growth, prioritizing quality, cost control, and a focused product strategy, with team integration and leadership as key drivers.
Expanded into New Jersey and prepared for significant growth in Minnesota, leveraging early-mover advantages and actively pursuing distressed asset opportunities.
IFRS revenue was $5.4M and Adjusted EBITDA was $0.1M, with reported margins impacted by non-consolidation of New Jersey results.
Financial highlights
Achieved all-in four-wall production costs of $368 in Michigan and $348 in Oregon, with sub-$200 COGS for indoor production.
Pro Forma Revenue grew to $8.5M from $6.7M year-over-year; Pro Forma Adjusted EBITDA rose to $1.7M from $1.4M.
Yield improvements: Oregon saw a 23% year-over-year increase, with A flower yield up 21%.
Michigan EBITDA rebounded above $1 million, while Oregon faced pricing pressure and inventory sell-downs.
Cash and cash equivalents increased to $13.1M from $4.7M at year-end.
Outlook and guidance
Minnesota prioritized for new builds, with phase one targeting 10,000 sq ft and potential to double canopy, targeting initial entry by early 2027.
Anticipates Minnesota to generate surplus profits in early years and sees strong long-term opportunity.
New Jersey phase two expansion to proceed room by room, with full facility expected operational by mid-2026.
Ongoing evaluation of distressed asset acquisitions expected to contribute to growth in coming quarters.
Continued investment in branded product development and packaging upgrades across all markets.
Latest events from Grown Rogue International
- Returned to profitability with $2.5M net income, positive cash flow, and ongoing expansion.GRIN
Q2 202523 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025